Human monogenic disorders — a source of novel drug targets

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nature reviews genetics

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrg1828PMID 16534513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic and Additional Vascular Effects of Thiazolidinediones

  2012cited by this paper
• [International HapMap project].

  2005cited by this paper
• Complement Factor H Polymorphism in Age-Related Macular Degeneration

  2005cited by this paper
• The Repertoire of G-Protein–Coupled Receptors in Fully Sequenced Genomes

  2005cited by this paper
• Comparative genomics and gene expression analysis identifies BBS9, a new Bardet-Biedl syndrome gene.

  2005cited by this paper
• Encyclopedia of genetics, genomics, proteomics and bioinformatics.

  2005cited by this paper
• Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration

  2005cited by this paper
• Complement Factor H Polymorphism and Age-Related Macular Degeneration

  2005cited by this paper
• Increasing High-Density Lipoprotein Cholesterol in Dyslipidemia by Cholesteryl Ester Transfer Protein Inhibition: An Update for Clinicians

  2005cited by this paper
• Trastuzumab: Targeted Therapy for the Management of HER-2/neu-Overexpressing Metastatic Breast Cancer

  2005cited by this paper
• Applications of whole-genome high-density SNP genotyping

  2005cited by this paper
• Inhibiting protein-protein interactions using designed molecules.

  2005cited by this paper
• Association between the neuregulin 1 gene and schizophrenia: a systematic review.

  2005cited by this paper
• Target-based drug discovery: is something wrong?

  2005cited by this paper
• Genome-wide association studies for common diseases and complex traits

  2005cited by this paper
• Complexity of the genotype–phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes

  2005cited by this paper
• Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons.

  2005cited by this paper
• SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels.

  2005cited by this paper
• A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.

  2005cited by this paper
• Accurate Multiplex Polony Sequencing of an Evolved Bacterial Genome

  2005cited by this paper
• Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia

  2004cited by this paper
• Emerging classes of protein-protein interaction inhibitors and new tools for their development.

  2004cited by this paper
• Has the yo‐yo stopped? An assessment of human protein‐coding gene number

  2004cited by this paper
• FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes

  2004cited by this paper
• Progress in the development of melanocortin receptor selective ligands.

  2004cited by this paper
• Small-molecule inhibitors of protein–protein interactions: progressing towards the dream

  2004cited by this paper
• Implementing Large-Scale ENU Mutagenesis Screens in North America

  2004cited by this paper
• HUMAN GENOME EPIDEMIOLOGY (HuGE) REVIEWS Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence Review

  2004cited by this paper
• The multiple orthogonal tools approach to define molecular causation in the validation of druggable targets.

  2004cited by this paper
• Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain.

  2004cited by this paper
• Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q.

  2004cited by this paper
• Spectrum and frequency of FZD4 mutations in familial exudative vitreoretinopathy.

  2004cited by this paper
• From syndrome families to functional genomics

  2004cited by this paper
• Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.

  2004cited by this paper
• Novel mutation in FZD4 gene in a Japanese pedigree with familial exudative vitreoretinopathy.

  2004cited by this paper
• FDA publishes analysis of the pipeline problem

  2004cited by this paper
• Autosomal dominant familial exudative vitreoretinopathy in two Japanese families with FZD4mutations (H69Y and C181R)

  2004cited by this paper
• Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies.

  2004cited by this paper
• A gene-driven ENU-based approach to generating an allelic series in any gene

  2004cited by this paper
• Towards a mutant map of the mouse – new models of neurological, behavioural, deafness, bone, renal and blood disorders

  2004cited by this paper
• A review of CETP and its relation to atherosclerosis Published, JLR Papers in Press, September 1, 2004. DOI 10.1194/jlr.R400007-JLR200

  2004cited by this paper
• The promise of genomics to identify novel therapeutic targets

  2004cited by this paper
• Target identification and validation through genetics

  2004cited by this paper
• Modeling drug action in the mouse with knockouts and RNA interference

  2004cited by this paper
• Direct estimates of human per nucleotide mutation rates at 20 loci causing mendelian diseases

  2003cited by this paper
• Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility.

  2003cited by this paper
• How clinicians add to knowledge of development.

  2003cited by this paper
• Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

  2003cited by this paper
• Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity

  2003cited by this paper
• Target discovery

  2003cited by this paper
• Knockouts model the 100 best-selling drugs—will they model the next 100?

  2003cited by this paper
• The Newfoundland population: a unique resource for genetic investigation of complex diseases.

  2003cited by this paper
• Persistent hyperinsulinemic hypoglycemia of infancy

  2003cited by this paper
• Pharmacogenetics goes genomic

  2003cited by this paper
• Modulation of protein-protein interactions with small organic molecules.

  2003cited by this paper
• Using haplotype blocks to map human complex trait loci.

  2003cited by this paper
• Linkage of Osteoporosis to Chromosome 20p12 and Association to BMP2

  2003cited by this paper
• Efficient target-selected mutagenesis in zebrafish.

  2003cited by this paper
• Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease

  2003cited by this paper
• Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors.

  2003cited by this paper
• Maximizing serendipity: strategies for identifying ligands for orphan G-protein-coupled receptors.

  2003cited by this paper
• The International HapMap Project

  2003cited by this paper
• Recent Progress in Discovery of Small‐Molecule CCR5 Chemokine Receptor Ligands as HIV‐1 Inhibitors

  2003cited by this paper
• Target Discovery and Validation in the Post-Genomic Era

  2003cited by this paper
• The gene encoding phosphodiesterase 4D confers risk of ischemic stroke

  2003cited by this paper
• The Human Phenome Project

  2003cited by this paper
• Cystic fibrosis: A worldwide analysis of CFTR mutations—correlation with incidence data and application to screening

  2002cited by this paper
• Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.

  2002cited by this paper
• Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

  2002cited by this paper
• Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy

  2002cited by this paper
• Increased ABCA1 activity protects against atherosclerosis.

  2002cited by this paper
• Neuregulin 1 and susceptibility to schizophrenia.

  2002cited by this paper
• Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer.

  2002cited by this paper
• The druggable genome

  2002cited by this paper
• Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort.

  2002cited by this paper
• New drug targets for genomic cancer therapy: successes, limitations, opportunities and future challenges.

  2001cited by this paper
• A candidate prostate cancer susceptibility gene at chromosome 17p

  2001cited by this paper
• Role of HPC2/ELAC2 in hereditary prostate cancer.

  2001cited by this paper
• Human Genetics: Lessons from Quebec Populations1

  2001cited by this paper
• Human genetics: lessons from Quebec populations.

  2001cited by this paper
• The P2Y 12 receptor as a therapeutic target in cardiovascular disease

  2001cited by this paper
• Use of population isolates for mapping complex traits

  2000cited by this paper
• Pros and cons of inhibiting cholesteryl ester transfer protein

  2000cited by this paper
• Estimate of the mutation rate per nucleotide in humans.

  2000cited by this paper
• Online Mendelian Inheritance In Man (OMIM)

  2000cited by this paper
• Genetic disorders among Palestinian Arabs: 3. Autosomal recessive disorders in a single village.

  2000cited by this paper
• Enoxaparin, a Low Molecular Weight Heparin, Inhibits Platelet-Dependent Prothrombinase Assembly and Activity by Factor-Xa Neutralization

  2000cited by this paper
• Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

  2000cited by this paper
• The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.

  1999cited by this paper
• Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

  1999cited by this paper
• High genomic deleterious mutation rates in hominids

  1999cited by this paper
• Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

  1999cited by this paper
• Do essential genes evolve slowly?

  1999cited by this paper
• Linkage disequilibrium mapping in isolated populations: the example of Finland revisited.

  1998cited by this paper
• Glycoprotein IIb/IIIa integrin blockade.

  1998cited by this paper
• Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells

  1998cited by this paper
• A World Wide Web site for low-density lipoprotein receptor gene mutations in familial hypercholesterolemia: sequence-based, tabular, and direct submission data handling.

  1998cited by this paper
• The impact of epoetin alfa on quality of life during cancer chemotherapy: a fresh look at an old problem.

  1997cited by this paper
• Gitelman's variant of Barter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na–Cl cotransporter

  1996cited by this paper
• Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.

  1994cited by this paper

• An atlas of TF driven gene programs across human cells

  2025cites this paper
• Genes that cause severe liver disease in children also influence risk and severity of common liver conditions in adults

  2025cites this paper
• Shared etiology of Mendelian and complex disease supports drug discovery

  2024influential citation
• Shared etiology of Mendelian and complex disease supports drug discovery

  2024influential citation
• Mendelian disease comorbidity as a resource for novel therapeutic targets

  2023cites this paper
• From target discovery to clinical drug development with human genetics

  2023cites this paper
• A Drug Discovery Approach for an Effective Pain Therapy through Selective Inhibition of Nav1.7

  2022cites this paper
• A genetically supported drug repurposing pipeline for diabetes treatment using electronic health records

  2022cites this paper
• Anti-Selection & Genetic Testing in Insurance: An Interdisciplinary Perspective

  2022cites this paper
• Assembling Disease Networks From Causal Interaction Resources

  2021cites this paper
• A COMPREHENSIVE REVIEW ON GENETICS AND ITS IMPACT ON HUMAN DISEASES

  2021cites this paper
• Immunity and Genetics at the Revolving Doors of Diagnostics in Primary Immunodeficiencies

  2021cites this paper
• Integrating Patient-Specific Information into Logic Models of Complex Diseases: Application to Acute Myeloid Leukemia

  2021cites this paper
• Monogenic Immune Diseases Provide Insights Into the Mechanisms and Treatment of Chronic Graft-Versus-Host Disease

  2021cites this paper
• Applications of Functional Genomics for Drug Discovery

  2020cites this paper
• New Technologies in Pre- and Postnatal Diagnosis

  2020cites this paper
• Multiparametric Assays for Accelerating Early Drug Discovery.

  2020cites this paper
• DrPOCS: Drug Repositioning Based on Projection Onto Convex Sets

  2019cites this paper
• Integration of target discovery, drug discovery and drug delivery: A review on computational strategies.

  2019cites this paper
• Systems Chemical Genetics-Based Drug Discovery: Prioritizing Agents Targeting Multiple/Reliable Disease-Associated Genes as Drug Candidates

  2019cites this paper
• Evolutionary and genetic features of drug targets

  2018cites this paper
• Towards Personalized Medicine: Computational Approaches to Support Drug Design and Clinical Decision Making

  2018cites this paper
• The Use of Transcriptomics in Clinical Applications

  2018cites this paper
• Facilitating Anti-Cancer Combinatorial Drug Discovery by Targeting Epistatic Disease Genes

  2018cites this paper
• Drug screening for human genetic diseases using iPSC models.

  2018influential citation
• Autozygome and high throughput confirmation of disease genes candidacy

  2018cites this paper
• Clinical Genetics and Heritable Parathyroid Disease: Monogenic Disorders

  2017cites this paper
• Genetics-directed drug discovery for combating Mycobacterium tuberculosis infection

  2017cites this paper
• Concise Review: Patient‐Derived Stem Cell Research for Monogenic Disorders

  2016cites this paper
• Scientific Support for Genetically-Targeted Therapies : Investigating the Hypothesis of Technological Hype

  2016cites this paper
• Discovery of mutations for Mendelian disorders

  2016cites this paper
• Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review.

  2016cites this paper
• Novel mechanisms involving B cell receptor (BCR) and B cell activating factor (BAFF) signaling pathways underlying human primary immunodeficiencies and malignancy

  2016cites this paper
• Tailored Pig Models for Preclinical Efficacy and Safety Testing of Targeted Therapies

  2016cites this paper
• A genomics-based systems approach towards drug repositioning for rheumatoid arthritis

  2016cites this paper
• A Chemical-Genetic Criterion for Identifying Disease Biomarkers.

  2016cites this paper
• A Call for Systematic Research on Solute Carriers.

  2015cites this paper
• A comparative study of disease genes and drug targets in the human protein interactome

  2015cites this paper
• Genetic similarity between cancers and comorbid Mendelian diseases identifies candidate driver genes

  2015cites this paper
• Computational drug repositioning for cancer therapeutics.

  2015cites this paper
• The necessity for in vivo functional analysis in human medical genetics.

  2015cites this paper
• Medical genetics-based drug repurposing for Alzheimer's disease.

  2015cites this paper
• Combining Human Disease Genetics and Mouse Model Phenotypes towards Drug Repositioning for Parkinson's disease.

  2015cites this paper
• Calcium Dependent Regulatory Mechanism inWolfram Syndrome: A Dissertation

  2015cites this paper
• Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases

  2015cites this paper
• Dissecting Traditional Chinese Medicines by Omics and Bioinformatics

  2014cites this paper
• Allelic Variation, Aneuploidy, and Nongenetic Mechanisms Suppress a Monogenic Trait in Yeast

  2014cites this paper
• Finding chemical drugs for genetic diseases.

  2014cites this paper
• Gene therapy : what it is , what it is not and what it will be

  2013cites this paper
• Functional genomics of the rat neuromedin U receptor 1 reveals a naturally occurring deleterious allele.

  2013cites this paper
• Reply to Science-based risk assessment requires careful evaluation of all studies

  2013cites this paper
• Structural and Energetic Analyses of SNPs in Drug Targets and Implications for Drug Therapy

  2013cites this paper
• Target Identification and Validation

  2013cites this paper
• Where do health benefits of flavonoids come from? Insights from flavonoid targets and their evolutionary history.

  2013cites this paper
• Hereditary diffuse leukoencephalopathy with spheroids: Insights into an adult onset neurodegenerative disease

  2013cites this paper
• A truncating mutation of Alms1 reduces the number of hypothalamic neuronal cilia in obese mice

  2013cites this paper
• Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation

  2013cites this paper
• Principles of Therapeutics

  2012cites this paper
• Can medical genetics and evolutionary biology inspire drug target identification?

  2012cites this paper
• Revisiting Mendelian disorders through exome sequencing

  2011cites this paper
• Funds dedicated to personalized genetics

  2011cites this paper
• Human genetics and genomics a decade after the release of the draft sequence of the human genome

  2011cites this paper
• Mendelian disorders of membrane trafficking.

  2011cites this paper
• Las enfermedades raras : naturaleza, características e intervención biopsicosocial

  2011cites this paper
• Terapia gênica: o que é, o que não é e o que será

  2010cites this paper
• Saturation of the Human Phenome

  2010cites this paper
• Oligogenic basis of isolated gonadotropin-releasing hormone deficiency

  2010cites this paper
• [Rare diseases, an emergent paradigm in the medicine of the XXI century].

  2010cites this paper
• Evolution of the human ion channel set.

  2009cites this paper
• Robust physical methods that enrich genomic regions identical by descent for linkage studies: confirmation of a locus for osteogenesis imperfecta

  2009cites this paper
• HYPOSPADIAS : GENE MAPPING AND CANDIDATE GENE STUDIES

  2009cites this paper
• Hypospadias : Gene mapping and candidate gene studied

  2009cites this paper
• [Genetically based diseases].

  2008cites this paper
• Identifying modifier genes of monogenic disease: strategies and difficulties

  2008cites this paper
• [Rare diseases: medicine's challenge in the XXI Century].

  2008cites this paper
• The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer’s disease

  2008cites this paper
• On the use of different mass spectrometric techniques for characterization of sequence variability in genomic DNA

  2008cites this paper
• Structural Basis for Selective Inhibition of Trypanosomatid Glyceraldehyde-3-Phosphate Dehydrogenase: Molecular Docking and 3D QSAR Studies

  2008cites this paper
• A 25-year longitudinal analysis of treatment efficacy in inborn errors of metabolism.

  2008cites this paper
• Enfermedades de base genética

  2008cites this paper
• Enfermedades de base genética Genetically based diseases

  2008cites this paper
• Enfermedades raras: el reto de la medicina en el siglo XXI

  2008cites this paper
• UNIVERSIDADE DE SÃO PAULO INSTITUTO DE FÍSICA DE SÃO CARLOS

  2008cites this paper
• New perspectives for the elucidation of genetic disorders.

  2007cites this paper
• Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, cause hereditary peripheral neuropathy with hearing loss and optic neuropathy (cmtx5).

  2007cites this paper
• Genetic association meets RNA interference: large-scale genomic screens for causation and mechanism of complex diseases.

  2007cites this paper
• Lessons from “Lower” Organisms: What Worms, Flies, and Zebrafish Can Teach Us about Human Energy Metabolism

  2007cites this paper
• Targetability of human disease genes.

  2007cites this paper
• [Research into the human genome driven by improved methods].

  2006cites this paper
• Integrating Large-Scale Genotype and Phenotype Data

  2006cites this paper
• Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred

  2006cites this paper
• Moderne Methoden in der Genomforschung und Humangenetik

  2006cites this paper
• Drosophila as a Model Organism for Investigating Molecular and Cellular Etiologies Underlying Complex Neurological Disorders in Humans

  2006cites this paper
• Hum Genet . Author Manuscript Identifying Modifier Genes of Monogenic Disease: Strategies and Difficulties G N Tique Pid Miologique Et Structures Des Populations Humaines

  year unknowncites this paper